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Exposure to cigarette smoke is one of the most discussed topics today, with its many aspects ranging from medical outcomes to social and legal aspects. Problems of passive 
smoking, such as an increased risk for the incidence of sudden 
infant death and respiratory tract diseases such as decreased 
pulmonary function, pneumonia, bronchitis, and otitis media, are 
among current topics of discussion [1,2].
Four major proteins are reported that are functionally important 
and form a surfactant compound. These are called surfactant 
proteins (SP) A, B, C, and D. SP-A and SP-D are influential in 
the defense system of the lungs, and they are believed to be the 
components of the immune system that first interact with and 
identifies a pathogen. They are very effective in binding of the 
encapsulated bacteria, enhancing of the antibacterial effects of 
alveolar macrophages, opsonization of viruses, and in an increase 
of the phagocytosis of pneumocystis carinii. In addition, they 
regulate the inflammatory response of the lungs and prevent 
an excessive inflammatory response by suppressing some of 
the neutrophil functions. They are also important for the use of 
surfactants which become structurally and functionally impaired 
over time in the making of new surfactants (recycling) by being 
taken into Type II cells and for the protection of surfactants from 
inactivation by inactivating plasma proteins [3,4].
Smoking affects local SP A and D levels negatively [5]. 
Reduced surfactant material and progressive damage to Type II 
cells were detected in the lung lavages of rats exposed to cigarette 
smoke [5]. It has been determined that the frequency of attacks 
increases in chronic obstructive pulmonary disease (COPD) 
patients with a high serum SP-D level [5]. There are no studies 
on the effect of cigarette smoking or exposure to cigarette smoke 
on SP-A and D levels in children as far as we know. The aim of 
this study was to detect SP A and D levels in children exposed to 
cigarette smoke.
MATERIALS AND METHODS
This cross-sectional study was conducted between December 
2012 and September 2013. This study confirmed to the principles 
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Background: Depending on the degree of exposure to cigarette smoke, various health problems can emerge in children. It 
is needed to have biochemical data of passive smoking to define the risks and to count the benefits of anti-smoking responses. 
Objective: The objective of the study was to evaluate the effect of smoke exposure on the surfactant protein (SP) A and D by 
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study was conducted between December 2012 and September 2013. İn this study, total 79 children were included who were admitted 
to the general pediatric outpatient clinic of a medical university. Out of them, 51 children were exposed to cigarette smoke and 28 
children were not exposed to cigarette smoke. In a survey was applied to evaluate the smoke exposure, and urinary cotinine levels 
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of the 2008 Declaration of Helsinki and was approved by the local 
ethics committee (approval number: 20.06.2013/12067). Informed 
consent was obtained from the parents of the children who were 
included in the study. A total of 79 children were included in the 
study who was admitted to the general pediatric outpatient clinic 
of a medical university. Among them, 51 children were exposed 
to cigarette smoke and 28 children were not exposed to cigarette 
smoke. Those who were exposed to environmental cigarette 
smoke although they did not smoke themselves (belonging to 
the family where at least 1 cigarette is smoked per day or those 
with at least 2 h of exposure to environmental cigarette smoke) 
were identified as passive smokers, and those with no smokers 
in the family and who were not exposed to cigarette smoke were 
identified as the control group. The children whose complete 
blood count, biochemistry, urine analysis, and chest X-ray results 
were not in normal ranges or children with additional diseases, 
were excluded from the study.
The data were collected by the researcher, using a face-to-
face interview technique. The study was explained to the parents 
of the children, and they were provided with a questionnaire 
and informed that blood and urine samples would be collected 
from their children. The questionnaire contained information 
such as - the interviewee’s degree of kinship to the child, their 
socioeconomic status, and their demographic information. It was 
asked whether the mother smoked during pregnancy, whether the 
father was a smoker and how much he smoked, whether there 
was any other smoker than the father and the mother in the house 
and how much they smoked, number of cigarettes smoked per 
day in the household, how the house was heated, and whether the 
child or other members of the family had a condition requiring 
regular check-ups and regular drug use. Urine samples were taken 
for urine cotinine level with an objective criterion of exposure to 
cigarette smoke. The body weight and height of every child were 
measured.
Test principle included the collection of urine samples from all 
children in sterile and capped urine containers (for urine cotinine 
levels). At the same time, 5 cc blood samples were collected in 
heparin-washed tubes to be studied for SP A and D. The collected 
blood samples were centrifuged for 10 min at 3000 rpm, and the 
separated serums were stored at −80°C until the date of the study. 
Assignment of urine cotinine levels was carried out with the 
enzyme immunoassay method, using the ROCHE HITACHI 912 
device. Cotinine levels were calculated in ng/ml. Serum SP A and 
serum SP D levels were measured with the ELISA method, using 
the “BioVendor Research and Diagnostic Products” brand kit.
RESULTS
A total of 79 children were included in the study, and they were 
divided into two groups based on cigarette smoke exposure. The 
demographic and anthropometric data for both the groups are 
given in Table 1. The difference between the groups in terms of 
sex ratios (p=0.56) as well as in terms of age, weight, height, and 
body mass index values p>0.05 was not statistically significant.
The mean urine cotinine level was statistically significantly 
higher in the passive smoker group compared to the control group 
(p<0.001). The mean serum SP-A level and the serum SP-D level 
were higher in passive smoker group than the control group was 
higher in the group exposed to cigarette smoke compared to the 
non-exposed group, this was not statistically significant (p=0.067) 
(Table 2). There was a correlation between the mean cotinine level 
and SP-A level of the group exposed to cigarette smoke (r=0.257, 
p=0.02). No correlation was found for SP-D (r=−0.06, p=0.67). 
Children’s mean urine cotinine level and SP-A and SP-D values 
according to exposure to cigarette smoke are given in Table 2.
SP-A and D levels were higher among those who were in 
an environment where >10 pcs/day of cigarettes were smoked 
compared to those who were in an environment where <10 pcs/day 
of cigarettes were smoked. The SP-A level was found to be 
statistically significant, but the SP-D levels were not statistically 
significant (Table 3).
DISCUSSION
Exposure to cigarette smoke is one of the most discussed topics 
today, with its many aspects ranging from medical outcomes 
to sociological and legal aspects. When this topic is handled 
in terms of children’s exposure, it is observed that children are 
usually exposed to cigarette smoke due to close family members 
who smoke. Depending on the degree of exposure to cigarette 
Table 1: Comparison of the mean age, weight, height, and BMI 
values of the groups
Parameters 
Tested
Exposed to 
cigarette smoke, 
n: 51
Not exposed to 
cigarette smoke 
n: 28
pb
Sex (M/F) 25/26 14/14 0.56
Age (years) 2.6±1.79a 2.3±1.77a 0.80
Weight (kg) 10.7±3.7a 10.5±4.5a 0.93
Height (cm) 84.13±15.12a 82.13±18.23a 0.82
BMI (kg/m2) 14.8±0.85a 15.02±0.52a 0.34
aGiven as mean±SD. bThe Mann–Whitney U test was used. BMI: Body mass index, 
SD: Standard deviation
Table 2: Urine cotinine, SP‑A, and SP‑D values of the groups
Parameters 
Tested
Exposed to CS, 
n: 51
Not exposed to 
CS, n: 28
pb
SP-A (U/L) 2.64±0.78a 2.2±0.76a 0.033
SP-D (U/L) 13.5±3.6a 12.1±2.8a 0.067
Cotinine (ng/ml) 622.27±600.66a,b 4.25±7.5a,b <0.001
aGiven as mean±SD. bThe Mann–Whitney U test was used. SD: Standard deviation, 
SP: Surfactant protein
Table 3: SP‑A and SP‑D levels according to the number of 
cigarettes smoked
Cigarettes >10 pcs, n: 15 <10 pcs, n: 32 pb
SP-A (U/L) 3.49±0.8a 2.3±0.45a <0.001
SP-D (U/L) 14.5±3.9a 13.2±3.4a 0.248
aGiven as mean±SD. bThe Mann–Whitney U test was used. SD: Standard deviation, 
SP: Surfactant protein
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smoke, various health problems can emerge in children. The most 
important of these problems are intrauterine growth restriction 
in babies, low birth weight, perinatal and neonatal mortality, 
decreased pulmonary function, bronchitis, pneumonia, asthma, 
otitis media, neurodevelopmental delay, behavioral problems, 
decline in school achievement, and sudden infant death [6,7].
SP-A and SP-D, which are among collections, are proteins 
that contribute to the regulation of the immune and inflammatory 
responses of the lungs and play an important role in the innate 
immune system against inhaled microorganisms and allergens. 
They play a role in protection against both viral, bacterial, and 
fungal infections, and apoptotic cells [3,4,8]. Intra-alveolar 
surfactant clearance was significantly reduced in mice with 
congenital SP-D deficiency (knockout). In this case, surfactant 
lipids and SP-A and SP-B gradually accumulate in the alveoli, 
resulting in the activation of alveolar macrophages and the 
development of peribronchial-perivascular inflammation and 
emphysema [9,10].
All oxidants, directly and indirectly, cause the formation of free 
radicals. The presence of a strong oxidant level causes low levels 
of antioxidants. The formation of low levels of the antioxidants 
plays a role in the pathogenesis of many diseases. There are many 
antioxidants in plasma. The TAS has been reported to represent all 
antioxidants [11,12]. In a study by Shermatov et al. [13], passive 
smoking was observed as a leading cause of DNA damage in children.
It has been found that the particles taken in by smoking interact 
with the surface film layer of the surfactant and change the active 
structure by decreasing the maximum surface area. Progressive 
damage in the Type II cells, from which SP-A and SP-D are 
secreted, of rats exposed to cigarette smoke and decreased 
surfactant material in their lung lavages were detected [5]. In 
our study, the SP-A level was significantly higher in the passive 
smoking group compared to the control group. While the serum 
SP-D level was higher in the passive smoking group, this was not 
statistically significant. To the best of our knowledge, there are 
no studies evaluating serum SP-A and SP-D levels in children 
exposed to cigarette smoke. For this reason, we could not compare 
our results with a similar study. However, a number of previous 
studies have evaluated bronchoalveolar lavage (BAL) fluid and 
SP-A and SP-D levels in adult smokers.
In a study by Lomas et al. [14], serum SP-D concentrations 
were higher in smokers compared to non-smokers. El-Deek 
et al. [15] found the serum SP-D levels of COPD patients to be 
significantly higher compared to the control group. In addition, 
serum levels of SP-D were significantly higher in smokers with 
COPD compared to non-smokers with COPD. They also found 
a significant negative correlation between pulmonary function 
test results and serum SP-D levels. These data suggest that the 
serum SP-D level is a promising biomarker for monitoring the 
progression of COPD [15].
In the study conducted by Ozyurek et al. [16], it was determined 
that exposure to smoking increases the serum SP-D level while 
decreasing the SP-D level in BAL. SP-D levels were found to 
be low in the inductive sputum of active smokers who were not 
using inhaled corticosteroids. This result indicates the importance 
of airway inflammation in the pathogenesis of COPD. In patients 
with COPD with a high serum SP-D level, the frequency of COPD 
attacks was found to have increased within a 6-month period.
Haeberle et al. [17] found that SP-A and SP-D levels in the 
BAL fluid were lower in patients with respiratory syncytial virus 
(RSV) compared to subjects in the control group. The SP-A, B, and 
D levels in the BAL fluid collected from more severe RSV patients 
connected to ventilators were shown to be lower compared to those 
who were not connected to a ventilator. This severe infection is 
due to the prolongation of viral persistence in the lungs and shows 
that SPs are associated with viral clearance [18,19].
The finding that serum SP-A and SP-D levels are highly 
detected in patients with pulmonary inflammation such as 
idiopathic pulmonary fibrosis, pneumonia, tuberculosis, submassive 
pulmonary embolism, and pulmonary damage suggests that 
pulmonary inflammation spreads systemically circulating SP-A 
and SP-D released from Type II pneumocytes in the lung [20,21].
Only serum levels were assessed in our study. SP-A and SP-D 
levels in BAL were not checked because our study involved 
healthy children and it was ethically not possible to perform a 
bronchoscopy. In addition to studies that only evaluate serum 
levels like our study, there are also studies that evaluate both BAL 
and serum levels in the literature [22].
Removal of excess or inactive surfactants from the alveolar 
space is possible through pinocytosis by pneumocyte II, other 
epithelial cells, and macrophages, through being pushed toward 
the upper respiratory tract with the help of cilium and intra-
alveolar pressure, or through passing the alveolar epithelium 
and capillary endothelium and mixing with blood [23,24]. The 
fact that SP-A and SP-D are released only from peripheral lung 
tissue supports the idea that pulmonary inflammation spreads to 
systemic circulation [23]. In light of this information, the fact 
that the serum level is associated with the BAL level shows that 
checking serum levels are adequate for showing SP-A and SP-D 
levels. For this reason, we believe that our SP-A and SP-D values 
provide reliable information.
We aimed to look at the correlation between serum SP-A and 
SP-D levels and the number of cigarettes smoked to evaluate 
the relationship between the degree of cigarette smoke exposure 
and serum SP-A and SP-D levels. However, since the number of 
cigarettes smoked was learned based on the questionnaire, it was 
taken as more or less than 10 pcs/day. In our study, the serum 
SP-A level was statistically significantly higher in those who were 
in an environment where >10 pcs/day of cigarettes are smoked 
compared to those found in an environment where <10 pcs/day 
of cigarettes are smoked. While the SP-D level was also high, 
this was not statistically significant. There was also a correlation 
between the serum SP-A level and the urine cotinine level, 
which is an objective criterion for exposure to cigarette smoke. A 
study by Lomas et al. [14] found a positive correlation between 
cigarette consumption (packs/year) and serum SP-D levels. These 
results suggest that the serum SP-A level, an indicator of anti-
inflammatory response, increases due to increased inflammation 
with exposure to cigarette smoke.
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A questionnaire was carried out, and urine cotinine levels 
were measured to assess cigarette smoke exposure in our study. It 
is reported in various studies that information provided by parents 
on children’s exposure to cigarette smoke does not correlate with 
the cotinine levels measured in children’s urine; therefore, this 
information alone cannot be sufficient [24,25]. These results 
demonstrate the necessity of studying the cotinine level, which 
is an objective criterion, in addition to the information provided 
by families when determining exposure to cigarette smoke in 
children. In our study, the urine cotinine level the group exposed 
to cigarette smoke was significantly higher than that of the group 
not exposed to cigarette smoke.
Our study is the first study to evaluate serum SP-A and SP-D 
levels in children exposed to cigarette smoke as far as we know. 
This study shows that cigarette smoke affects the levels of SP-A 
and SP-D, which are among the most important substances of 
innate immunity in the lungs, and causes an increase in serum SP-A 
and SP-D levels as a response to the pulmonary inflammation that 
it causes. Cotinine, an objective indicator of exposure to cigarette 
smoke, is valuable in terms of ensuring the reliability of the results.
The limitation of this study was that while the serum SP-D 
level was high, the difference was not statistically significant and 
is related to the number of subjects. It will be useful to support this 
finding with other studies to be done. We think that re-examination 
of these children with long follow-up studies will be important for 
the evaluation of our findings. Cigarette smoke-free living areas 
must be provided for children. Prevention of exposure of children 
to this contaminant due to the adoption of more applicable legal 
and administrative measures, the development of advanced 
laboratory techniques to assist in the identification of problems 
and the public’s awareness of the public’s health.
CONCLUSION
In this study, SP-A and SP-D levels are higher than the children 
who are not exposed to environmental tobacco smoke may be 
interpreted as lung inflammation and lung injury and residues in 
response to inflammation in the lungs exposed to cigarette smoke.
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